...
tlph-img

Talphera Inc., Common Stock

TLPH

NMQ

$0.6571

-$0.04

(-5.71%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$15.29M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
71.76K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.33
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.62 L
$1.61 H
$0.6571

About Talphera Inc., Common Stock

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameTLPHSectorS&P500
1-Week Return-3.37%-2.82%0.15%
1-Month Return-27.79%-4.22%1.78%
3-Month Return-26.99%-9.52%8.7%
6-Month Return-32.95%-3.45%12.24%
1-Year Return-1.93%5.62%30.9%
3-Year Return-93.68%3.8%30.19%
5-Year Return-98.58%39.68%91.72%
10-Year Return-99.49%105.02%203.2%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue2.29M5.42M2.82M1.77M651.00K[{"date":"2019-12-31","value":42.26,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":52.03,"profit":true},{"date":"2022-12-31","value":32.7,"profit":true},{"date":"2023-12-31","value":12.02,"profit":true}]
Cost of Revenue6.81M6.03M3.75M2.59M5.55M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":88.63,"profit":true},{"date":"2021-12-31","value":55.14,"profit":true},{"date":"2022-12-31","value":38.07,"profit":true},{"date":"2023-12-31","value":81.49,"profit":true}]
Gross Profit(4.52M)(616.00K)(935.00K)(820.00K)(4.89M)[{"date":"2019-12-31","value":-451700000,"profit":false},{"date":"2020-12-31","value":-61600000,"profit":false},{"date":"2021-12-31","value":-93500000,"profit":false},{"date":"2022-12-31","value":-82000000,"profit":false},{"date":"2023-12-31","value":-489500000,"profit":false}]
Gross Margin(197.34%)(11.37%)(33.18%)(46.30%)(751.92%)[{"date":"2019-12-31","value":-197.34,"profit":false},{"date":"2020-12-31","value":-11.37,"profit":false},{"date":"2021-12-31","value":-33.18,"profit":false},{"date":"2022-12-31","value":-46.3,"profit":false},{"date":"2023-12-31","value":-751.92,"profit":false}]
Operating Expenses49.69M40.35M35.03M20.35M17.54M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":81.2,"profit":true},{"date":"2021-12-31","value":70.5,"profit":true},{"date":"2022-12-31","value":40.96,"profit":true},{"date":"2023-12-31","value":35.3,"profit":true}]
Operating Income(54.20M)(40.96M)(35.97M)(25.30M)(16.89M)[{"date":"2019-12-31","value":-5420500000,"profit":false},{"date":"2020-12-31","value":-4096300000,"profit":false},{"date":"2021-12-31","value":-3596500000,"profit":false},{"date":"2022-12-31","value":-2530000000,"profit":false},{"date":"2023-12-31","value":-1688900000,"profit":false}]
Total Non-Operating Income/Expense-1.18M1.74M84.82M13.20M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":1.39,"profit":true},{"date":"2021-12-31","value":2.05,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":15.57,"profit":true}]
Pre-Tax Income(53.24M)(40.38M)(35.09M)59.14M(10.29M)[{"date":"2019-12-31","value":-90.02,"profit":false},{"date":"2020-12-31","value":-68.27,"profit":false},{"date":"2021-12-31","value":-59.34,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-17.39,"profit":false}]
Income Taxes3.00K4.00K5.00K13.00K14.85M[{"date":"2019-12-31","value":0.02,"profit":true},{"date":"2020-12-31","value":0.03,"profit":true},{"date":"2021-12-31","value":0.03,"profit":true},{"date":"2022-12-31","value":0.09,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes-(40.38M)(35.10M)59.13M(25.13M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-68.29,"profit":false},{"date":"2021-12-31","value":-59.36,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-42.51,"profit":false}]
Income From Continuous Operations-(40.38M)(35.10M)59.13M(10.29M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-68.29,"profit":false},{"date":"2021-12-31","value":-59.36,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-17.4,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(53.24M)(40.38M)(35.10M)47.76M(18.40M)[{"date":"2019-12-31","value":-111.49,"profit":false},{"date":"2020-12-31","value":-84.55,"profit":false},{"date":"2021-12-31","value":-73.5,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-38.52,"profit":false}]
EPS (Diluted)(13.45)(9.58)(5.88)-5.99[{"date":"2019-12-31","value":-224.47,"profit":false},{"date":"2020-12-31","value":-159.93,"profit":false},{"date":"2021-12-31","value":-98.16,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

TLPH
Cash Ratio 4.02
Current Ratio 4.42

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

TLPH
ROA (LTM) -47.26%
ROE (LTM) -118.40%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

TLPH
Debt Ratio Lower is generally better. Negative is bad. 0.54
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.46

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

TLPH
Trailing PE NM
Forward PE NM
P/S (TTM) 38.43
P/B 1.20
Price/FCF NM
EV/R 12.53
EV/Ebitda 0.11

FAQs

What is Talphera Inc. share price today?

Talphera Inc. (TLPH) share price today is $0.6571

Can Indians buy Talphera Inc. shares?

Yes, Indians can buy shares of Talphera Inc. (TLPH) on Vested. To buy Talphera Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TLPH stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Talphera Inc. be purchased?

Yes, you can purchase fractional shares of Talphera Inc. (TLPH) via the Vested app. You can start investing in Talphera Inc. (TLPH) with a minimum investment of $1.

How to invest in Talphera Inc. shares from India?

You can invest in shares of Talphera Inc. (TLPH) via Vested in three simple steps:

  • Click on Sign Up or Invest in TLPH stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Talphera Inc. shares
What is Talphera Inc. 52-week high and low stock price?

The 52-week high price of Talphera Inc. (TLPH) is $1.61. The 52-week low price of Talphera Inc. (TLPH) is $0.62.

What is Talphera Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Talphera Inc. (TLPH) is

What is Talphera Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Talphera Inc. (TLPH) is 1.20

What is Talphera Inc. dividend yield?

The dividend yield of Talphera Inc. (TLPH) is 0.00%

What is the Market Cap of Talphera Inc.?

The market capitalization of Talphera Inc. (TLPH) is $15.29M

What is Talphera Inc.’s stock symbol?

The stock symbol (or ticker) of Talphera Inc. is TLPH

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top